Recent condom use by arrested injection drug users in King County, Washington, USA

International Journal of Drug Policy

Volumn 17, Issue 3, 2006, Pages 222-229

  Burt, Richard D ^a   Thiede, Hanne ^a   Barash, Elizabeth T ^a   Sabin, Keith ^b  

^a Public Health Seattle King County   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Condoms; HIV; Injection drug users

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDOM; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MALE; PREVALENCE; PRIORITY JOURNAL; PRISON; PROSTITUTION; PUBLIC HEALTH; RISK REDUCTION; SCREENING; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALITY; SOCIAL ASPECT; TIME; UNITED STATES; VIRUS TRANSMISSION;

EID: 33744509781     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2006.03.007     Document Type: Article

References (37)

1. Anderson J.E. Condom use and HIV risk among US adults. American Journal of Public Health 93 (2003) 912-914
2. Asiimwe-Okiror G., Opio A.A., Musinguzi J., Madraa E., Tembo G., and Carael M. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 11 (1997) 1757-1763
3. Battjes R.J., Pickens R.W., and Brown Jr. L.S. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 (1995) 90-96
4. Centers for Disease Control and Prevention. Trends in sexual risk behaviors among high school students-United States, 1991-1997. Morbidity and Mortality Weekly Report 47 (1998) 749-752
5. Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005 (2001), Centers for Disease Control and Prevention, Atlanta, GA
6. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2004. (Vol. 16, Rep. No. 15) (2005), U.S. Department of Health and Human Services, Atlanta, GA
7. Colfax G., Coates T.J., Husnik M.J., Huang Y., Buchbinder S., Koblin B., et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health 82 (2005) i62-i70
8. Davis K.R., and Weller S.C. The effectiveness of condoms in reducing heterosexual transmission of HIV. Family Planning Perspectives 31 (1999) 272-279
9. Des Jarlais D.C., Perlis T., Friedman S.R., Chapman T., Kwok J., Rockwell R., et al. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990-1997. American Journal of Public Health 90 (2000) 1112-1116
10. Fennema J.S., Van Ameijden E.J., Van Den H.A., and Coutinho R.A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 92 (1997) 1457-1465
11. Friedman S.R., Tempalski B., Cooper H., Perlis T., Keem M., Friedman R., et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health 81 (2004) 377-400
12. Gregson S., Garnett G.P., Nyamukapa C.A., Hallett T.B., Lewis J.J., Mason P.R., et al. HIV decline associated with behavior change in eastern Zimbabwe. Science 311 (2006) 664-666
13. Harris N.V., Thiede H., McGough J.P., and Gordon D. Risk factors for HIV infection among injection drug users: Results of blinded surveys in drug treatment centers, King County, Washington, 1988-1991. Journal of Acquired Immune Deficiency Syndromes 6 (1993) 1275-1282
14. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., and Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet 357 (2001) 1397-1401
15. Longshore D., Annon J., and Anglin M.D. Long-term trends in self-reported HIV risk behavior: Injection drug users in Los Angeles, 1987 through 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 (1998) 64-72
16. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6 (1993) 1049-1056
17. Molitor F., Ruiz J.D., Flynn N., Mikanda J.N., Sun R.K., and Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug Alcohol Abuse 25 (1999) 475-493
18. Moss A.R., Vranizan K., Gorter R., Bacchetti P., Watters J., and Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 8 (1994) 223-231
19. National Institute of Allergy and Infectious Diseases. Workshot summary: Scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention (2000), National Institutes of Health, Department of Health and Human Services, Herndon, VA
20. Nelson K.E., Celentano D.D., Eiumtrakol S., Hoover D.R., Beyrer C., Suprasert S., et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. New England Journal of Medicine 335 (1996) 297-303
21. Nicolosi A., Leite M.L., Musicco M., Molinari S., and Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: A study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. American Journal of Epidemiology 135 (1992) 225-233
22. O'Driscoll P.T., McGough J., Hagan H., Thiede H., Critchlow C., and Alexander E.R. Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health 91 (2001) 984-987
23. Piccinino L.J., and Mosher W.D. Trends in contraceptive use in the United States: 1982-1995. Family Planning Perspectives 30 (1998) 4-10, 46
24. Pinkerton S.D., and Abramson P.R. Effectiveness of condoms in preventing HIV transmission. Social Science & Medicine 44 (1997) 1303-1312
25. Rhodes T., Donoghoe M., Hunter G., Soteri A., and Stimson G.V. Sexual behaviour of drug injectors in London: Implications for HIV transmission and HIV prevention. Addiction 89 (1994) 1085-1096
26. Semaan S., Kotranski L., Collier K., Lauby J., Halbert J., and Feighan K. Temporal trends in HIV risk behaviors of out-of-treatment injection drug users and injection drug users who smoke crack. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19 (1998) 274-281
27. Solomon L., Astemborski J., Warren D., Munoz A., Cohn S., Vlahov D., et al. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. American Journal of Epidemiology 137 (1993) 892-898
28. Sonenstein F.L., Ku L., Lindberg L.D., Turner C.F., and Pleck J.H. Changes in sexual behavior and condom use among teenaged males: 1988 to 1995. American Journal of Public Health 88 (1998) 956-959
29. Sonenstein F.L., Pleck J.H., and Ku L.C. Sexual activity, condom use and AIDS awareness among adolescent males. Family Planning Perspectives 21 (1989) 152-158
30. Strathdee S.A., Galai N., Safaiean M., Celentano D.D., Vlahov D., Johnson L., et al. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine 161 (2001) 1281-1288
31. Thiede H., Romero M., Bordelon K., Hagan H., and Murrill C.S. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. Journal of Urban Health 78 (2001) 264-278
32. Tyndall M.W., Patrick D., Spittal P., Li K., O'Shaughnessy M.V., and Schechter M.T. Risky sexual behaviours among injection drugs users with high HIV prevalence: Implications for STD control. Sexually Transmitted Infections 78 Suppl. 1 (2002) i170-i175
33. Van Ameijden E.J., van den Hoek J.A., and Coutinho R.A. Large declines in sexual risk behavior with noncommercial partners among heterosexual injection drug users in Amsterdam, 1989-1995. American Journal of Epidemiology 144 (1996) 772-781
34. Watkins K.E., Metzger D., Woody G., and McLellan A.T. Determinants of condom use among intravenous drug users. AIDS 7 (1993) 719-723
35. Watters J.K. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. Journal of Acquired Immune Deficiency Syndromes 7 (1994) 1276-1281
36. Weller S.C., and Davis K.R. Condom effectiveness in reducing heterosexual HIV transmission (Review). The Cochrane Library 2 (2005) (Chichester, UK: John Wiley & Sons)
37. Wiebel W.W., Jimenez A., Johnson W., Ouellet L., Jovanovic B., Lampinen T., et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A 4-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12 (1996) 282-289